Saldinvest Kft.

The trials here

What the 2 trials at this site are about, from their registry records.

Conditions

• Ankylosing spondylitis1 trial
• Rheumatoid arthritis1 trial

Phase

• Phase 32 trials

Status

• Completed2 trials

Lead sponsor

• AbbVie2 trials

Closed trials

• Completed

  Study to Assess Change in Disease Activity and Adverse Events of Oral Upadacitinib Compared to Subcutaneous Adalimumab in Adult Participants With Moderate to Severe Rheumatoid Arthritis

  NCT05814627· Phase 3· AbbVie· Source

• Completed

  A Study to Evaluate Efficacy and Safety of Upadacitinib in Adults With Axial Spondyloarthritis

  NCT04169373· Phase 3· AbbVie· Source